PE20061149A1 - COMPOSITIONS CONTAINING PIPERACILIN AND TAZOBACTAM - Google Patents
COMPOSITIONS CONTAINING PIPERACILIN AND TAZOBACTAMInfo
- Publication number
- PE20061149A1 PE20061149A1 PE2005001201A PE2005001201A PE20061149A1 PE 20061149 A1 PE20061149 A1 PE 20061149A1 PE 2005001201 A PE2005001201 A PE 2005001201A PE 2005001201 A PE2005001201 A PE 2005001201A PE 20061149 A1 PE20061149 A1 PE 20061149A1
- Authority
- PE
- Peru
- Prior art keywords
- salt
- acid
- piperacilin
- tazobactam
- composition
- Prior art date
Links
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: a) DE 8 mg/ml A 500 mg/ml DE PIPERACILINA; b) DE 0,1 mg/ml A 125 mg/ml TAZOBACTAM; c) DE 0,002 mg/ml A 10 mg/ml DE UN ACIDO AMINOCARBOXILICO SELECCIONADO DE EDTA O UNA SAL DE EDTA COMO SAL CALCICA DISOCA, SAL DICALCICA, SAL DE DIAMONIO, SAL DIPOTASICA, ENTRE OTROS INCLUYENDO ACIDO DIETILENTRIAMINOPENTAACETICO (DPTA), ACIDO HIDROXIETILENDIAMINOTRIACETICO (HEDTA), ACIDO NITRILOACETICO (NTA) Y d) UN TAMPON UN DILUYENTE DE LACTATO DE SODIO SELECCIONADO DE SOLUCION DE RINGER LACTADA, SOLUCION DE HARTMANN, ACIDO CITRICO O UNA SAL DEL MISMO DONDE EL CITRATO SE ENCUENTRA EN EL INTERVALO DE 0,25mg/ml A 25mg/ml. LA COMPOSICION ALCANZA UN pH DE 6,5. LA COMPOSICION FARMACEUTICA PUEDE COMPRENDER ADEMAS UN AMINOGLUCOSIDO SELECCIONADO DE AMIKACINA Y TOBRAMICINA PRESENTES EN UN INTERVALO DE 0,1 mg/ml A 75 mg/ml. LA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE UNA INFECCION BACTERIANAIT REFERS TO A PHARMACEUTICAL COMPOSITION WHICH INCLUDES: a) FROM 8 mg / ml TO 500 mg / ml OF PIPERACILIN; b) FROM 0.1 mg / ml TO 125 mg / ml TAZOBACTAM; c) FROM 0.002 mg / ml TO 10 mg / ml OF A SELECTED AMINOCARBOXYL ACID FROM EDTA OR AN EDTA SALT SUCH AS CALCICA DISOCA SALT, DICALCICA SALT, DIAMMONIUM SALT, DIPOTASSIC SALT, BETWEEN OTHERS INCLUDING DIETHYLENTRAMINE THYNOPENTAACETICOHYL ACID (HEDTA), NITRILOACETIC ACID (NTA) AND d) A BUFFER A SODIUM LACTATE DILUENT SELECTED FROM LACTED RINGER SOLUTION, HARTMANN SOLUTION, CITRIC ACID OR A SALT OF THE SAME WHERE THE CITRATE IS IN THE INTERVAL OF 0.25mg / ml to 25mg / ml. THE COMPOSITION REACHES A pH OF 6.5. THE PHARMACEUTICAL COMPOSITION MAY ALSO INCLUDE A SELECTED AMINOGLUCOSIDE OF AMIKACIN AND TOBRAMYCIN PRESENT IN A RANGE OF 0.1 mg / ml TO 75 mg / ml. THE COMPOSITION IS USEFUL FOR THE TREATMENT OF A BACTERIAL INFECTION
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61887204P | 2004-10-14 | 2004-10-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061149A1 true PE20061149A1 (en) | 2006-12-18 |
Family
ID=37715928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005001201A PE20061149A1 (en) | 2004-10-14 | 2005-10-11 | COMPOSITIONS CONTAINING PIPERACILIN AND TAZOBACTAM |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN101035532A (en) |
| AR (1) | AR051745A1 (en) |
| GT (1) | GT200500285A (en) |
| PE (1) | PE20061149A1 (en) |
| TW (1) | TW200618812A (en) |
| UA (1) | UA89204C2 (en) |
| ZA (1) | ZA200703067B (en) |
-
2005
- 2005-10-11 PE PE2005001201A patent/PE20061149A1/en not_active Application Discontinuation
- 2005-10-12 TW TW094135501A patent/TW200618812A/en unknown
- 2005-10-12 CN CN 200580033889 patent/CN101035532A/en active Pending
- 2005-10-12 UA UAA200704093A patent/UA89204C2/en unknown
- 2005-10-13 AR ARP050104292 patent/AR051745A1/en not_active Application Discontinuation
- 2005-10-13 GT GT200500285A patent/GT200500285A/en unknown
-
2007
- 2007-04-13 ZA ZA200703067A patent/ZA200703067B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101035532A (en) | 2007-09-12 |
| AR051745A1 (en) | 2007-02-07 |
| GT200500285A (en) | 2006-05-11 |
| TW200618812A (en) | 2006-06-16 |
| ZA200703067B (en) | 2008-08-27 |
| UA89204C2 (en) | 2010-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP077387A (en) | COMPOSITIONS CONTAINING PIPERACILIN, TAZOBACTAM AND AN AMINOCARBOXYL ACID IN A SODIUM LACTATE DILUENT | |
| AR043863A1 (en) | COMPOSITIONS CONTAINING PIPERACILIN AND TAZOBACTAM, USEFUL FOR INJECTION | |
| RS52566B (en) | Liquid lh formulations | |
| AR067011A1 (en) | FORMULATIONS OF ANTIBODIES | |
| ATE538774T1 (en) | PHARMACEUTICAL FORMULATIONS AND METHODS FOR TREATING RESPIRATORY INFECTIONS | |
| GEP20125628B (en) | Pharmaceutical compositions containing antagonist anti-cd40 antibody | |
| DE602005021770D1 (en) | INDOLE-1-YL-ACETIC DERIVATIVES | |
| EP4233892A3 (en) | Stable anti-ifnar1 formulation | |
| ATE545407T1 (en) | PHARMACEUTICAL FORMULATION OF APOMORPHINE FOR BUCCAL ADMINISTRATION | |
| WO2010100200A3 (en) | Lyophilised antibody formulation | |
| HRP20020787B1 (en) | Method of treatment using ligand-immunogen conjugates | |
| PE20100152A1 (en) | {5- [4- (6-CYANO-PYRIDIN-3-ILMETOXY) -PHENIL] - [1,2,4] TRIAZOL [1,5-a] PYRIDIN-2-IL} -AMIDE OF CYCLOPROPANCARBOXYL ACID AND COMPOSITIONS THAT THEY UNDERSTAND IT | |
| BR0114799A (en) | Cyanophenoxy carboxylic acid compounds and compositions for releasing active agents | |
| UY27320A1 (en) | NEW PHARMACEUTICAL COMPOSITIONS | |
| EA200401522A1 (en) | ANTITUBERCULAR PREPARATION: COMPOSITIONS AND METHODS | |
| NO20075111L (en) | Pharmaceutical composition | |
| AR074541A1 (en) | NATURAL SILVER DISINFECTANT COMPOSITIONS | |
| EA200601874A1 (en) | LIQUID COMPOSITION OF GROWTH HORMONE | |
| IL186058A0 (en) | Polymorphs of 3-0-(3',3' -dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine salt | |
| PE20061149A1 (en) | COMPOSITIONS CONTAINING PIPERACILIN AND TAZOBACTAM | |
| PE20130180A1 (en) | ORAL PHARMACEUTICAL SOLUTIONS INCLUDING TELBIVUDINE | |
| WO2004105492A8 (en) | Aqueous compositions for disinfection and/or sterilization | |
| AR047809A1 (en) | A SOLID, NOT GRANULATED CLEANING COMPOSITION | |
| DE602005018609D1 (en) | IMPROVED FORMULATION FOR REDUCING THE PH VALUE | |
| PE20070787A1 (en) | AQUEOUS COMPOSITION OF A SODIUM AZIDE AMMONIA SOLUTION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |